Latest papers

Cell communications in the heart.

Identification of potent and selective amidobipyridyl inhibitors of protein kinase D.

Identification of orally available naphthyridine protein kinase D inhibitors.

NADPH oxidase and cardiac failure.

A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection.

MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.

Revisited and revised: is RhoA always a villain in cardiac pathophysiology?

Nifedipine inhibits cardiac hypertrophy and left ventricular dysfunction in response to pressure overload.

Tafazzin knockdown causes hypertrophy of neonatal ventricular myocytes.

Chromatin regulation by Brg1 underlies heart muscle development and disease.

Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice.

Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.

Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway.

Regulation and role of myocyte cyclic GMP-dependent protein kinase-1.

Intracellular translocation of calmodulin and Ca2+/calmodulin-dependent protein kinase II during the development of hypertrophy in neonatal cardiomyocytes.

Reciprocal regulation of transcription factors and PLC isozyme gene expression in adult cardiomyocytes.

Lack of beta3 integrin signaling contributes to calpain-mediated myocardial cell loss in pressure-overloaded myocardium.

Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.

Magnetic resonance imaging-aided diagnosis of an inferior sinus venosus defect: a case report.

Size, shape, and stamina: the impact of left ventricular geometry on exercise capacity.